Related Experiment Video
Updated: Aug 17, 2026

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Progressive chronic kidney disease after pediatric lung transplantation
S Paul Hmiel1, Anne M Beck, Maria Theresa de la Morena
1Department of Pediatrics, Washington University Medical School, St. Louis Children's Hospital, St. Louis, MO, USA. hmiel@kids.wustl.edu
Insights
Pediatric lung transplant recipients often develop chronic kidney disease (CKD). Renal function significantly declines post-transplant, especially in adolescents, with cystic fibrosis linked to poorer outcomes.
Area of Science:
- Nephrology
- Pediatric Transplant Surgery
- Immunology
Background:
- Chronic kidney disease (CKD) is a concern in pediatric solid organ transplant recipients.
- Long-term renal function data after pediatric lung transplantation is limited.
Purpose of the Study:
- To evaluate the incidence and progression of CKD in pediatric lung transplant recipients.
- To identify risk factors associated with renal dysfunction post-transplant.
Main Methods:
- Retrospective chart review of 125 pediatric patients undergoing first lung transplant and surviving one year.
- Analysis of serum creatinine and estimated glomerular filtration rate (eGFR) over time.
- Kaplan-Meier analysis to assess renal survival based on age and diagnosis.
Main Results:
- Serum creatinine nearly doubled by one year and tripled by seven years post-transplant.
- eGFR significantly decreased, with 38% reaching eGFR < 60 mL/min by five years.
- Older age at transplant and cystic fibrosis diagnosis were associated with reduced renal survival.
Conclusions:
- Pediatric lung transplant recipients experience substantial renal function loss over time.
- Adolescents and patients with cystic fibrosis face a higher risk of developing CKD.
- Long-term renal monitoring is crucial for this patient population.
Abstract:
The development of chronic kidney disease (CKD) was evaluated in a large cohort of pediatric lung transplant recipients. Retrospective chart review identified 125 patients undergoing first lung transplant at St. Louis Children's Hospital and surviving 1 year. Mean age at transplant was 10.3 +/- 0.55 years, while mean time after transplant was 4.9 years. Serum creatinine nearly doubled from baseline 0.48 mg/dL +/- 0.02 (n = 125) to 0.87 mg/dL +/- 0.04 (n = 120) at 1 year, and tripled to 1.39 mg/dL +/- 0.15 (n = 23) by 7 years after transplant. The glomerular filtration rate (GFR), as estimated by the Schwartz formula, decreased from baseline 163 +/- 5.9 mL/min/1.73 m(2) (n = 109) to 88 +/- 2.5 (n = 104), reaching 69 +/- 9.0 (n = 6) by 10 years (p < 0.01). Seven patients developed end-stage kidney disease, and by 5 years after transplant, 38% of patients reached GFR < 60 mL/min. Older age at transplant and primary diagnosis of cystic fibrosis (CF) were both associated with decreased renal survival by Kaplan-Meier (KM) analysis. In summary, pediatric lung transplant recipients experience significant loss of renal function over time, as observed in other solid organ transplant recipients, and is most dramatic in adolescents.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
